home / stock / hbp / hbp news


HBP News and Press, Huttig Building Products Inc. From 10/25/19

Stock Information

Company Name: Huttig Building Products Inc.
Stock Symbol: HBP
Market: NASDAQ
Website: huttig.com

Menu

HBP HBP Quote HBP Short HBP News HBP Articles HBP Message Board
Get HBP Alerts

News, Short Squeeze, Breakout and More Instantly...

HBP - Helix BioPharma Corp. Announces Fiscal 2019 Year-End Results

RICHMOND HILL, Ontario, Oct. 25, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”), an immuno-oncology company developing drug candidates for the prevention and treatment of cancer, today announced its financial results for the year ended July 31, 2019. FINANCIAL...

HBP - Huttig Building Products, Inc. Schedules Third Quarter 2019 Earnings Call

ST. LOUIS, Oct. 16, 2019 (GLOBE NEWSWIRE) -- Huttig Building Products (Nasdaq: HBP), one of the nation's largest wholesale distributors of millwork and specialty building products used principally in new residential construction and home improvement, plans to release its third quarter 2019 ...

HBP - AZEK Building Products and Huttig Building Products Expand Their Partnership

CHICAGO, Oct. 01, 2019 (GLOBE NEWSWIRE) -- AZEK Building Products and Huttig Building Products (Nasdaq: HBP) have announced a new partnership intended to service key areas in the Washington and Oregon markets. Huttig Building Products, one of the nation’s largest wholesale distributo...

HBP - Helix BioPharma Corp. and Moffit Cancer Centre to Present at World Molecular Imaging Congress

RICHMOND HILL, Ontario, Sept. 03, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, is pleased to announce that they,...

HBP - Helix BioPharma Corp. Closes $7.0 Million Private Placement

RICHMOND HILL, Ontario, Aug. 21, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: “HBP”) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, today announced it ...

HBP - Helix Biopharma Corp. Receives U.S. FDA Approval for Phase Ib/II Pancreatic Trial

RICHMOND HILL, Ontario, Aug. 07, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, announced that it has received app...

HBP - Huttig Building Products, Inc. (HBP) CEO Jon Vrabely on Q2 2019 Results - Earnings Call Transcript

Huttig Building Products, Inc. (HBP) Q2 2019 Results Conference Call July 30, 2019 11:00 AM ET Company Participants Philip Keipp - Vice President and Chief Financial Officer Jon Vrabely - President and Chief Executive Officer Bob Furio - Executive Vice President and Chief Operati...

HBP - Huttig Building Products reports Q2 results

Huttig Building Products (NASDAQ: HBP ): Q2 GAAP EPS of -$0.40. More news on: Huttig Building Products, Inc., Earnings news and commentary, , Read more ...

HBP - Huttig Building Products, Inc. Announces Second Quarter 2019 Results

Second Quarter 2019 Highlights: Net sales of $218.5 million Operating income increased 57% to $3.3 million Operating cash needs reduced by $15.6 million Successfully completed a major enterprise resource planning system upgrade ST. LOUIS, July 29, 2019 (GLOBE NEWSWIRE...

HBP - Helix Biopharma Corp. to Present at RHK Capital Conference in New York

RICHMOND HILL, Ontario, July 24, 2019 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX: HBP), (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and treatment of cancer, announces that it will be presenti...

Previous 10 Next 10